← All candidates
Two insider buys in the last year — $28.85M in all.
28 filings on record.
AVRAnteris Technologies Global Corp.
NasdaqGM · Healthcare · $815.73M
$8.37
+0.36% · Sep 16
Two insider buys in the last year — $28.85M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 2 buys● 13 sells◆ 13 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$815.73M
Float
66.0M
68% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
363.8
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
L1 Capital Pty Ltd
Bought $28.75M on Jan 22 — 5,000,000 sh @ $5.75, held indirect, 38% of their stake.
1 of 1 position beat the S&P
Director
Knight Susan Elizabeth
Bought $102.2K on Jun 2 — 11,000 sh @ $9.29, held direct, 100% of their stake.
First Form 4 on file
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
23 more transactions on Pro →Context
Wall St
$16.00 avg target
+91.2% vs today · 4 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 3 quarters beat
Q4 '25−$0.75 act−$0.19
Q3 '25−$0.62 act−$0.05
Q2 '25−$0.58 act−$0.10
Coverage
France clearance marks key milestone for Anteris' pivotal PARADIGM TrialProactive · 06-08Here's Why We're Not Too Worried About Anteris Technologies Global's (ASX:AVR) Cash Burn SituationSimply Wall St. · 05-13Anteris adds Susan Knight, Stephen Denaro to board as company advances heart valve strategyProactive · 05-13Anteris advances PARADIGM trial as Q1 cash burn reflects commercialisation pushProactive · 05-12
The file stays open
28 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice